Molecular Pathways: Targeting the PI3K Pathway in Cancer-BET Inhibitors to the Rescue
about
BET inhibitors: a novel epigenetic approach.PI3K inhibitor enhances the cytotoxic response to etoposide and cisplatin in a newly established neuroendocrine cervical carcinoma cell line.Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis.Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells.
P2860
Molecular Pathways: Targeting the PI3K Pathway in Cancer-BET Inhibitors to the Rescue
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Molecular Pathways: Targeting the PI3K Pathway in Cancer-BET Inhibitors to the Rescue
@en
type
label
Molecular Pathways: Targeting the PI3K Pathway in Cancer-BET Inhibitors to the Rescue
@en
prefLabel
Molecular Pathways: Targeting the PI3K Pathway in Cancer-BET Inhibitors to the Rescue
@en
P2860
P1476
Molecular Pathways: Targeting the PI3K Pathway in Cancer-BET Inhibitors to the Rescue
@en
P2093
Elias E Stratikopoulos
Ramon E Parsons
P2860
P304
P356
10.1158/1078-0432.CCR-15-2389
P407
P577
2016-06-01T00:00:00Z